Expensify, Inc. (EXFY) — insider trading
Information Technology · Nasdaq
Expensify, Inc. (EXFY) has 29 reported SEC Form 4 insider transactions in our data, including 6 open-market sales among the most recent 29 (latest 2026-07-05).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-07-05 | Liu Ying | Director | Grant / award / vesting | 3,731 | $0.00 | $0 | Form 4 |
| 2026-06-23 | Barrett David Michael | Director, Officer (Chief Executive Officer) | Grant / award / vesting (derivative) | 2,031,280 | $0.00 | $0 | Form 4/A |
| 2026-06-23 | Barrett David Michael | Director, Officer (Chief Executive Officer) | Grant / award / vesting (derivative) | 63,694 | $0.00 | $0 | Form 4/A |
| 2026-06-23 | Barrett David Michael | Director, Officer (Chief Executive Officer) | Grant / award / vesting (derivative) | 2,094,974 | $0.00 | $0 | Form 4 |
| 2026-06-23 | Mills Jason Fahr | Director | Grant / award / vesting (derivative) | 1,160,447 | $0.00 | $0 | Form 4 |
| 2026-06-23 | Schaffer Ryan | Director, Officer (Chief Financial Officer) | Grant / award / vesting (derivative) | 1,164,596 | $0.00 | $0 | Form 4 |
| 2026-06-23 | Vidal Daniel | Director | Grant / award / vesting (derivative) | 1,160,447 | $0.00 | $0 | Form 4 |
| 2026-06-15 | Alvarez Divo Carlos Eduardo | Director | Open-market sale | 10,700 | $1.28 | $13.7K | Form 4 |
| 2026-05-22 | Christen Timothy L | Director | Grant / award / vesting | 123,762 | $0.00 | $0 | Form 4 |
| 2026-05-22 | Liu Ying | Director | Grant / award / vesting | 123,762 | $0.00 | $0 | Form 4 |
| 2026-05-22 | Pao Ellen | Director | Grant / award / vesting | 123,762 | $0.00 | $0 | Form 4 |
| 2026-03-30 | Alvarez Divo Carlos Eduardo | Director | Open-market sale | 12,451 | $0.81 | $10.1K | Form 4 |
| 2026-03-24 | Vidal Daniel | Director | Open-market sale | 1,510 | $0.84 | $1.3K | Form 4 |
| 2026-03-24 | Alvarez Divo Carlos Eduardo | Director | Open-market sale | 1,699 | $0.84 | $1.4K | Form 4 |
| 2026-03-20 | Alvarez Divo Carlos Eduardo | Director | Grant / award / vesting | 33,633 | $0.00 | $0 | Form 4 |
| 2026-03-17 | Vidal Daniel | Director | Open-market sale | 6,158 | $0.76 | $4.7K | Form 4 |
| 2026-03-17 | Alvarez Divo Carlos Eduardo | Director | Open-market sale | 6,230 | $0.76 | $4.7K | Form 4 |
| 2026-03-15 | Vidal Daniel | Director | Option exercise / conversion (derivative) | 2,826 | $0.00 | $0 | Form 4 |
| 2026-03-15 | Vidal Daniel | Director | Option exercise / conversion (derivative) | 2,826 | $0.00 | $0 | Form 4 |
| 2026-03-15 | Vidal Daniel | Director | Option exercise / conversion (derivative) | 2,826 | $0.00 | $0 | Form 4 |
| 2026-03-15 | Vidal Daniel | Director | Option exercise / conversion | 2,826 | — | — | Form 4 |
| 2026-03-15 | Alvarez Divo Carlos Eduardo | Director | Option exercise / conversion (derivative) | 2,467 | $0.00 | $0 | Form 4 |
| 2026-03-15 | Alvarez Divo Carlos Eduardo | Director | Option exercise / conversion (derivative) | 2,467 | $0.00 | $0 | Form 4 |
| 2026-03-15 | Alvarez Divo Carlos Eduardo | Director | Option exercise / conversion (derivative) | 2,467 | $0.00 | $0 | Form 4 |
| 2026-03-15 | Alvarez Divo Carlos Eduardo | Director | Option exercise / conversion | 2,467 | — | — | Form 4 |
| 2026-03-13 | Vidal Daniel | Director | Grant / award / vesting | 20,925 | $0.00 | $0 | Form 4 |
| 2026-03-13 | Vidal Daniel | Director | Grant / award / vesting | 72,413 | $0.82 | $59.4K | Form 4 |
| 2026-03-13 | Alvarez Divo Carlos Eduardo | Director | Grant / award / vesting | 16,359 | $0.00 | $0 | Form 4 |
| 2026-03-13 | Alvarez Divo Carlos Eduardo | Director | Grant / award / vesting | 59,500 | $0.82 | $48.8K | Form 4 |
Ask the chat about EXFY's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: Expensify, Inc. (EXFY).
Last updated 2026-07-05 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.